Webinar: The Spectacular Role of the Human Microbiome in Preventing Metabolic Endotoxemia
You are more bacteria than you are human with 10 trillion human cells outnumbered by over 100 trillion bacteria cells in and on your body. The human genome contributes just 1% genetic material to daily metabolic function compared to the 99% that is contributed by the microbiome. An often-overlooked role of the microbiome is to prevent post-prandial endotoxemia and the inflammatory devastation that follows. This lecture will illustrate the danger of having post-prandial endotoxemia and why this condition is being called the number one cause of mortality worldwide as it sets up the body for virtually every chronic disease. This condition is caused by eating and a failure of the microbiome to protect its host from this response. You simply cannot completely correct any chronic condition without addressing post-prandial endotoxemia.
- The latest understanding on the form and function of the human microbiome.
- The development and establishment of the human microbiome and factors that disrupt optimal development.
- How the microbiome controls the immune system, the brain, the endocrine system and nutrient production – the critical cross-talk between microbe and host.
- Understanding post-prandial endotoxemia (PPE) and its resulting effects on the human body.
- Strategies for probiotic therapy that can impact PPE.
- The role of transient, commensal spore based probiotics in bacteriotherapy to treat PPE.
Kiran Krishnan, Microbiologist & Chief Science Officer, Microbiome Labs
Kiran Krishnan is a Research Microbiologist and has been involved in the dietary supplement and nutrition market for the past 16 years. He comes from a strict research background having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa. Mr. Krishnan earned his Bachelor of Science degrees in Microbiology at the University of Iowa; his undergraduate education was followed up with post graduate research in Molecular Biology and Virology. He left University research to take a position as the U.S. Business Development and Product Development lead for Amano Enzyme, USA. Amano is one of the world’s largest suppliers of therapeutic enzymes used in the dietary supplement and pharmaceutical industries in North America. Kiran also established a Clinical Research Organization where he designed and conducted over a dozen human clinical trials in human nutrition. Kiran is also a co-founder and partner in Nu Science Trading, LLC.; a nutritional technology development, research and marketing company in the U.S. Dietary Supplement and Medical Food markets. Most recently, Kiran is acting as the Chief Scientific Officer at Physician’s Exclusive, LLC. and Microbiome Labs. He is a frequent lecturer on the Human Microbiome at Medical and Nutrition Conferences. He conducts the popular monthly Microbiome Series Webinars through the Rebel Health Tribe Group practitioner training program, he has been invited as an expert guest on National Radio and Satellite radio and has been a guest speaker in several Health Summits as a microbiome expert. He is currently involved in 3 novel human clinical trials on probiotics and the human microbiome. Kiran offers his extensive knowledge and practical application of the latest science on the human microbiome as it relates to health and wellness.